数据日期 2026-10-29 · 生成时间 2026-10-29 06:03
研究问题
AD is the most common cause of dementia, accounting for approximately 60–70% of all cases worldwide.
方法
（全文无独立方法节，正文亦未给出可抽取的实验动作句）
核心结论
Introduction AD is the most common cause of dementia, accounting for approximately 60–70% of all cases worldwide.；It is estimated that around 10% of individuals aged 65 years and older are affected by AD, with the prevalence increasing to 32% among those over 85 years of age [1].；The neuropathological hallmarks of AD include the accumulation of β-amyloid (Aβ) plaques in the extracellular space between neurons and the formation of intraneuronal neurofibrillary tangles composed of hyperphosphorylated tau protein [4,5,6,7,8]. ‖ 结论：These platforms deliver therapeutic cargoes directly to microglia, safely circumventing severe off-target peripheral toxicities.
局限
全文未设独立 limitations 节；结构上为综述/二次研究，因果推断强度受限。
对本项目的价值
★★☆☆☆ 脑老化是最大未满足需求，也是终点最难量化的领域；biomarker 与认知读数选择最敏感。设计 观察性、单细胞。
全文来源
PMC JATS 全文（正文 126,348 字符，已过标题/DOI 逐字归属校验）
原文题录
- 英文标题：Microglial Therapeutic Potential in Alzheimer's Disease: From Phenotypic Diversity to Targeted Interventions.
- 期刊与标识：Pharmaceuticals (Basel) · PMID 42943300 · DOI 10.3390/ph19101603**
C 级证据分级：C 级（预印本 / 观点评论，非原始研究）
本文属观点/评论类文献，不是原始研究。其论点依赖于作者对既有证据的梳理与判断，不构成新的实验证据。本站标注 C 级即为此意——阅读时请把它当作「领域内的思考框架」，而非「研究发现」。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写，依据已获取的期刊全文（方法、样本量与结论已回到原文核对）；未能获取全文的同批条目另行标注「摘要级」，全程未做任何数值推算补全。